Adaptimmune Therapeutics (NASDAQ:ADAP) Coverage Initiated by Analysts at StockNews.com
StockNews.com assumed coverage on shares of Adaptimmune Therapeutics (NASDAQ:ADAP – Free Report) in a research report report published on Tuesday. The firm issued a buy rating on the biotechnology company’s stock. ADAP has been the subject of a number of other reports. Wells Fargo & Company reduced their price objective on shares of Adaptimmune Therapeutics […]
StockNews.com assumed coverage on shares of Adaptimmune Therapeutics (NASDAQ:ADAP – Free Report) in a research report report published on Tuesday. The firm issued a buy rating on the biotechnology company’s stock. ADAP has been the subject of a number of other reports. Wells Fargo & Company reduced their price objective on shares of Adaptimmune Therapeutics […]
